Mannheim, July 5, 2022
The 3rd M²OLIE functional test provided a very good overview of the current state of developments at the Mannheim Research Campus. On this day, project staff from the M²OLIE team presented the respective progress at the stops along the patient pathway. This year’s test focused on the sub-processes that are components of the “Minimal Viable Closed-Loop”. The annual test showed that the work packages to be processed for this purpose are almost completely available for the smooth running of this section of the M²OLIE closed-loop process. Accordingly, it was successfully demonstrated that M²OLIE is on track to evaluate the Minimal Viable Closed-Loop in a clinical study next year. The functional test is an important tool in the Research Campus to sustainably integrate the multitude of medical and technical innovations in M²OLIE into the overall concept and thus realize the goal of a patient-centered and time-optimized infrastructure for cancer patients with oligometastases.